LEADER 01608nam  2200373Ia 450 
001 9910698835803321
005 20090522142308.0
035   $a(CKB)5470000002397509
035   $a(OCoLC)341605154
035   $a(EXLCZ)995470000002397509
100   $a20090522d2004      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aFDA and industry actions on premarket notification (510(k)) submissions, effect on FDA review clock and performance assessment$b[electronic resource]
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health :$cCenter for Biologics Evaluation and Research,$d[2004]
215   $a14 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on May 22, 2009).
300   $a"Document issued on: May 21, 2004".
517   $aFDA and industry actions on premarket notification 
606   $aUser charges$zUnited States
606   $aMedical instruments and apparatus$zUnited States$xEvaluation
615  0$aUser charges
615  0$aMedical instruments and apparatus$xEvaluation.
712 02$aCenter for Devices and Radiological Health (U.S.)
712 02$aCenter for Biologics Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698835803321
996   $aFDA and industry actions on premarket notification (510(k)) submissions, effect on FDA review clock and performance assessment$93174882
997   $aUNINA